Latest Breaking News On - Melvin toh - Page 1 : comparemela.com

CK Life Sciences to present Cancer Vaccine data at the 2024 American Association for Cancer Research (AACR) Annual Meeting

<div> HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach Newswire</a> - 5 April 2024 - CK Life Sciences Int’l., (Holdings) Inc. will be presenting new data from its cancer vaccine research pipeline at the 2024 American Association for Cancer Research (AACR) Annual Meeting in San Diego, California, USA.</div>

United statesHong kongSan diegoDong chenMelvin tohZhenghui wangChi han samson liTongren liuLipeng laiRuohan zhuQingxia zhangKenneth nansheng linXiangrui gaoSamson liYalong zhaoCklifesciences cancervaccines

XtalPi Inc : XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024

XtalPi Inc : XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesDong chenQingxia zhangTongren liuRuohan zhuLipeng laiTianyuan wangDennis riedlSamson liMelvin tohXiangrui gaoGenwei zhangYalong zhaoPrnewswire xtalpiZhenghui wang

XtalPi to Present the Latest Progress of Its AI Cancer Vaccine Design Platform at AACR 2024

/PRNewswire/ XtalPi, a leading global technology company in integrating artificial intelligence (AI) and robotics to advance the discovery of groundbreaking.

United statesDong chenSan diegoZhenghui wangPrnewswire xtalpiQingxia zhangSamson liRuohan zhuMelvin tohLipeng laiGenwei zhangTongren liuTianyuan wangXiangrui gaoYalong zhaoAmerican association for cancer research

XtalPi and CK Life Sciences Ink Agreement to Develop Cancer Molecular Diagnostic Models using AI and Biomarker Data

Today, XtalPi, a leading global technology company in combining artificial intelligence (AI) and robotics to drive the discovery of groundbreaking medicine and innovative materials, announced the signing of a new agreement with CK Life Sciences, a member of the CK Hutchison Group. Expanding upon their existing partnership, the two companies will combine AI algorithms with anonymized clinical and biomarker data from cancer patients and healthy individuals in CK Life Sciences' data repository to j

Hong kongLipeng laiMelvin tohStock exchange of hong kongCk life sciencesXtalpi incCk hutchison groupChief innovation officerVice presidentChief scientific officerStock exchangeClinical researchCancer patientsCk hutchisonBiomarker discoveryMolecular diagnosis

CK Life Sciences Presenting Preclinical Data for Its Investigational Dual-Antigen Cancer Vaccines, Co-targeting PRAME and PD-L1, at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting

<p>HONG KONG SAR - <a href="https://www.media-outreach.com/">Media OutReach</a> - 1 November 2023 - CK Life Sciences Int l., (Holdings) Inc. is presenting preclinical data for its investigational dual-antigen cancer vaccines, co-targeting PRAME (preferentially expressed antigen in melanoma) and PD-L1 (programmed death-ligand 1), on November 4<b> </b>at the 2023 Society for Immunotherapy of Cancer (SITC) Annual Meeting in San Diego, California, USA.</p>

United statesSan diegoHong kongShiotag gastrointestMelvin tohCklifesciences cancervaccinesHsin wei chenChen yi chiangGruaj cutanCk life sciencesCk life sciences intlStock exchange of hong kongSociety for immunotherapy of cancerHoldings incCk hutchison groupSciences int l